General literature
Machine Learning Solicitation for COVID 19

Mohanty S. N., Saxena S. K., Satpathy S., Chatterjee J. M.

Springer 2021, ISBN 978-981-15-7316-3.

General literature
Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry

Unger M. S., Blank M., Enzlein T., Hopf C.

Nat Protoc 2021, Nov 10.

DOI
PubMed
General literature
A precisely positioned MED12 activation helix stimulates CDK8 kinase activity

Klatt F., Leitner A., Kim I. V., Ho-Xuan H., Schneider E. V., Langhammer F., Weinmann R., Müller M. R., Huber R., Meister G., Kuhn C.

PNAS 2020, 117, (6), 2894-2905.

DOI
PUBMED
General literature
A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5

Hanke T., Wong J. F., Berger B., Abdi I., Berger L. M., Tesch R., Tredup C., Bullock A. N., Müller S., Knapp S.

ACS Chem. Biol. 2020, 15, (4), 862-870.

DOI
PUBMED
General literature
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity

Grandjean J. M., Jiu A. Y., West J.W., Aoyagi A., Droege D.G., Elepano M., Hirasawa M., Hirouchi M., Murakami R., Lee J., Sasaki K., Hirano S., Ohyama T., Tang B. C., Vaz R. J., Inoue M., Olson S. H., Prusiner S. B., Conrad J., Paras N.A.

ACS Med. Chem. Lett. 2020, 11, (2), 127–132. open access.

PUBMED
General literature
PAINS management: an open source model to eliminate nuisance compounds

Capuzzi S. J., Morris D. C.

Drug Target Review 2018. open access.

DOI